Danyelle Townsend | Molecular Pharmacology | Innovative Research Award

Published on by Molecular Biologist

Innovative Research Award

Danyelle Townsend
Medical University of South Carolina, United States

Danyelle Townsend
Affiliation Medical University of South Carolina
Country United States
Scopus ID 7202240755
Documents 173
Citations 14,308
h-index 53
Subject Area Molecular Pharmacology
Event International Molecular Biologist Awards
Google Scholar ID zaTtq2UAAAAJ

Danyelle Townsend is a molecular pharmacology researcher recognized for contributions in understanding biochemical mechanisms associated with cellular defense, drug response, and human disease. Her academic work has focused on glutathione metabolism, detoxification pathways, and molecular factors influencing therapeutic outcomes. This article presents a scholarly overview of her research profile and recognition through the Innovative Research Award.

Abstract

The research profile of Danyelle Townsend reflects sustained investigation into molecular pharmacology, particularly the biological roles of glutathione-related pathways. Her studies have contributed to broader understanding of oxidative stress, cancer biology, and cellular protection mechanisms. Key publications have examined glutathione functions and drug resistance processes. [1]

Keywords

Molecular Pharmacology; Glutathione; Cancer Research; Drug Resistance; Oxidative Stress; Biomedical Science.

Introduction

Molecular pharmacology investigates interactions between biological systems and therapeutic compounds. Research in this field provides insight into disease mechanisms and supports development of improved treatment strategies. Townsend’s work has emphasized molecular pathways that regulate cellular responses to environmental and therapeutic challenges. [2]

Research Profile

Danyelle Townsend is affiliated with the Medical University of South Carolina and has developed expertise in molecular mechanisms associated with pharmacological responses. Her scholarly record includes 173 documents, 14,308 citations, and an h-index of 53, demonstrating notable engagement within biomedical research literature.

Research Contributions

Major contributions include investigations into glutathione metabolism, glutathione-S-transferase activity, and molecular pathways affecting cancer therapy. These studies have provided evidence regarding antioxidant defense and mechanisms involved in therapeutic resistance. [3]

Publications

  • The importance of glutathione in human disease, 2003.
  • The role of glutathione-S-transferase in anti-cancer drug resistance, 2003.
  • Glutathione S-transferase polymorphisms: cancer incidence and therapy, 2006.

Research Impact

The impact of this research is reflected through citation activity and continued relevance of molecular detoxification pathways in biomedical science. The findings support ongoing investigations into personalized medicine and therapeutic optimization.

Award Suitability

The Innovative Research Award recognizes researchers whose work demonstrates scientific contribution, methodological advancement, and meaningful influence within their discipline. Townsend’s publication record and research focus align with these academic criteria.

Conclusion

Danyelle Townsend’s research represents sustained contributions to molecular pharmacology through studies of cellular defense mechanisms, drug resistance, and disease-related biochemical processes.

External Links

References

  1. Elsevier. (n.d.). Scopus author details: Danyelle Townsend, Author ID 7202240755. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7202240755
  2. Townsend DM, Tew KD. The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene. 2003;22:7369–7375.
  3. Townsend DM, Tew KD, Tapiero H. The importance of glutathione in human disease. Biomedicine & Pharmacotherapy. 2003;57:145–155.
    DOI: https://doi.org/10.1016/S0753-3322(03)00022-0
  4. Tapiero H, Townsend DM, Tew KD. The antioxidant role of selenium and seleno-compounds. Biomedicine & Pharmacotherapy. 2003;57:134–144.
  5. McIlwain CC, Townsend DM, Tew KD. Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene. 2006;25:1639–1648.

SRIDEVI CHIGURUPATI | Medicinal Chemistry | Excellence in Research

Published on by Molecular Biologist

Assoc. Prof. Dr. SRIDEVI CHIGURUPATI | Medicinal Chemistry | Excellence in Research 

Associate Professor, at COLLEGE OF PHARMACY, QASSIM UNIVERSITY, Saudi Arabia.

Dr. Sridevi Chigurupati, M.Pharm., Ph.D., AFMSA, FAGE, FIC, R.Ph (India), is an accomplished pharmaceutical scientist and educator specializing in medicinal chemistry and pharmacognosy. Currently, she serves as an Associate Professor at the College of Pharmacy, Qassim University, Saudi Arabia. With a rich academic and research background, she has made significant contributions to pharmaceutical sciences through her work in drug design, natural product chemistry, and pharmacological screening. Dr. Chigurupati has published extensively in high-impact journals and actively supervises postgraduate students in advanced research projects. She has received numerous prestigious awards recognizing her excellence in teaching and research. Her expertise in synthetic chemistry, molecular modeling, and biological activity evaluation has positioned her as a leading researcher in the field.

Professional Profile

Scopus

ORCID

Google Scholar

Education 🎓

Dr. Sridevi Chigurupati holds a Ph.D. in Pharmaceutical Sciences from Jawaharlal Nehru Technological University, Hyderabad, India (2006-2012). She earned her Master of Pharmacy in Medicinal Chemistry from Manipal College of Pharmaceutical Sciences, Manipal University (2003-2005), graduating with distinction as a college topper. Her Bachelor of Pharmacy degree was obtained from Nalanda College of Pharmacy, Osmania University (1998-2002), where she also secured first-class distinction. Her academic journey reflects her deep commitment to pharmaceutical sciences, leading to significant contributions in medicinal chemistry and drug research.

Experience 💼

Dr. Chigurupati has over 18 years of teaching and research experience in pharmaceutical sciences. She has served as an Associate Professor at Qassim University, Saudi Arabia (2018-present), and previously held academic positions at AIMST University, Malaysia (2013-2018), and Geethanjali College of Pharmacy, India (2007-2013). Her roles have encompassed teaching, supervising research students, and conducting groundbreaking studies in pharmaceutical chemistry. She has been instrumental in developing academic curricula, organizing workshops, and mentoring students for high-impact research publications.

Research Interests 🔬

Dr. Chigurupati’s research focuses on the synthesis and evaluation of novel chemical entities for various pharmacological activities. Her expertise includes in-vitro and in-vivo screening of new compounds, natural product chemistry, peptide synthesis, drug design, QSAR, and molecular modeling. She is particularly interested in antioxidant, anti-Alzheimer, antidepressant, anti-inflammatory, and antidiabetic studies. Her research also involves analytical techniques like UV, IR, NMR, and Mass Spectroscopy for evaluating synthesized and natural products.

Awards & Recognitions 🏆

Dr. Chigurupati has received several prestigious awards, including the “Best Research Project Award” from Qassim University (2023), “Best Woman Scientist Award” from Genesin of Educational Impressions (2023), and “Outstanding Woman Author of Research Paper Award” (2021). She also received the “Excellence in Teaching Award” (2021) and the “Best Oral Paper Presentation” award at an international conference (2021). Her previous accolades include the “Outstanding Woman in Health and Medical Sciences Award” (2018) and the “Q3 STAR Award” from AIMST University, Malaysia (2016). She has also secured multiple research grants for her innovative projects.

Top Noted Publications 📖

Dr. Chigurupati has authored numerous peer-reviewed articles in high-impact journals. Some notable publications include:

1. Medicinal Chemistry & Drug Discovery

  • Synthesis of pyridin-3-yl-1,3,4-oxadiazole and 5-p-tolyl-1,3,4-oxadiazole derivatives

    • Journal: Journal of Molecular Structure, 2025
    • Authors: Bibi Fatima, Faiza Saleem, Uzma Salar, Muhammad Taha, K.M. Khan
    • Focus: Antihyperglycemic, AChE/BuChE inhibition, antioxidant activities

  • Synthesis of novel indazole derivatives as inhibitors of diabetics II

    • Journal: Journal of Molecular Structure, 2025
    • Authors: Fatema al-Nasser, Muhammad Taha, Fazal Rahim, Shatha Ghazi Felemban, Vijayan Venugopal
    • Focus: Diabetes treatment, molecular docking & simulation

  • Synthesis, bioactivity, and molecular docking of pyrazole-bearing Schiff bases

    • Journal: Journal of Molecular Structure, 2025
    • Authors: Lotfi M. Aroua, Ibrahim S. Alkhaibari, Fahad M. Alminderej, Hamdoon Abdelhamid Mohammed, Abdul-Hamid Hamid Mohammad Emwas
    • Focus: Dual alpha-amylase & alpha-glucosidase inhibitors, antioxidants

  • Rhodanine-benzamides as potential α-amylase inhibitors and radical scavengers

    • Journal: Molecular Diversity, 2024
    • Authors: Samuel Attah Egu, Irfan Ali, K.M. Khan, Mohsin Ali, Muhammad Taha
    • Focus: Enzyme inhibition, antioxidant properties

2. AI & Computational Studies

  • Leveraging AI for the diagnosis and treatment of autism spectrum disorder

    • Journal: Asian Journal of Psychiatry, 2024
    • Authors: Nitu L. Wankhede, Mayur Bhimrao Kale, Madhu Shambhu Shukla, Spandana Rajendra Kopalli, Sushruta Koppula
    • Focus: AI applications in ASD diagnosis and therapy

  • Molecular docking & ADMET analysis of Zn(II) complexes as SARS-CoV-2 inhibitors

    • Journal: Turkish Computational and Theoretical Chemistry, 2024
    • Authors: M.N. Manjunatha, Sampath Chinnam, Malathi Challa, Swetha Madamala, Viola Tressa Fernandes
    • Focus: Drug design for COVID-19

3. Pharmacology & Neurobiology

  • Heme oxygenase-1’s role in neuroinflammation & depression

    • Journal: Phytomedicine, 2024
    • Authors: Jiao Wang, Tapan Behl, Tarapati Rana, Bairong Shen, Rajeev K. Singla
    • Focus: Phytotherapeutics for neuroinflammation & mental health

  • Endostatin’s role in Alzheimer’s disease (Erratum)

    • Journal: Environmental Science and Pollution Research, 2024
    • Authors: Dapinder Kaur, Tapan Behl, Sridevi Chigurupati, Lotfi Aleya, Simona Gabriela Bungau
    • Focus: Correction on Alzheimer’s research

4. Electrocatalysis & Medicinal Chemistry

  • Review on electrocatalytic nitrate reduction to ammonia

    • Journal: Ionics, 2024
    • Authors: C.R. Santhosh, Sampath Chinnam, Gattumane Motappa Madhu, Sridevi Chigurupati, Ravi Sankannavar
    • Focus: Advances in ammonia production via electrochemistry

  • Imidazo[1,2-a]pyridine derivatives as anticancer agents

    • Journal: Archiv der Pharmazie, 2024
    • Authors: Ankush Kumar, Vishakha Sharma, Tapan Behl, Sridevi Chigurupati, Monika K. Sachdeva
    • Focus: Cancer drug discovery

Conclusion

Dr. Sridevi Chigurupati is highly suitable for Research for Excellence in Research awards based on her academic excellence, significant research contributions, successful grants, and global recognition. Strengthening her high-impact publications, international collaborations, and industry partnerships would further enhance her research profile and competitiveness for prestigious global research awards.